CD8A and neoplasm: The surprising finding is that using the LSD1 inhibitor alone, despite its effective tumor suppression, the resulting exogenous TGF-1 binding to the CD8+ T cell surface receptors inhibits the cytotoxic effects (105), which may be one of the reasons why the clinical effects of LSD1 inhibitors are suboptimal.